nodes	percent_of_prediction	percent_of_DWPC	metapath
Anastrozole—breast cancer—ovarian cancer	0.714	1	CtDrD
Anastrozole—CYP19A1—Paclitaxel—ovarian cancer	0.0703	0.515	CbGbCtD
Anastrozole—CYP19A1—follicular fluid—ovarian cancer	0.0185	0.432	CbGeAlD
Anastrozole—CYP3A4—Topotecan—ovarian cancer	0.018	0.132	CbGbCtD
Anastrozole—CYP2C9—Paclitaxel—ovarian cancer	0.0153	0.112	CbGbCtD
Anastrozole—CYP3A4—Vinorelbine—ovarian cancer	0.0127	0.0929	CbGbCtD
Anastrozole—CYP19A1—corpus luteum—ovarian cancer	0.0107	0.249	CbGeAlD
Anastrozole—CYP3A4—Paclitaxel—ovarian cancer	0.00891	0.0653	CbGbCtD
Anastrozole—CYP19A1—ovarian follicle—ovarian cancer	0.00834	0.194	CbGeAlD
Anastrozole—CYP3A4—Docetaxel—ovarian cancer	0.00644	0.0472	CbGbCtD
Anastrozole—CYP3A4—Doxorubicin—ovarian cancer	0.0048	0.0352	CbGbCtD
Anastrozole—CYP19A1—endometrium—ovarian cancer	0.000825	0.0192	CbGeAlD
Anastrozole—CYP19A1—gonad—ovarian cancer	0.000765	0.0178	CbGeAlD
Anastrozole—CYP19A1—uterus—ovarian cancer	0.00076	0.0177	CbGeAlD
Anastrozole—CYP19A1—female reproductive system—ovarian cancer	0.000683	0.0159	CbGeAlD
Anastrozole—CYP19A1—female gonad—ovarian cancer	0.000622	0.0145	CbGeAlD
Anastrozole—CYP19A1—testis—ovarian cancer	0.000551	0.0129	CbGeAlD
Anastrozole—CYP2C9—female reproductive system—ovarian cancer	0.000435	0.0101	CbGeAlD
Anastrozole—CYP19A1—lymph node—ovarian cancer	0.0004	0.00933	CbGeAlD
Anastrozole—CYP3A4—female reproductive system—ovarian cancer	0.000331	0.00773	CbGeAlD
Anastrozole—CYP19A1—Ovarian Infertility Genes—NR5A1—ovarian cancer	0.000191	0.0528	CbGpPWpGaD
Anastrozole—CYP19A1—Ovarian Infertility Genes—INHA—ovarian cancer	0.000186	0.0513	CbGpPWpGaD
Anastrozole—CYP19A1—FSH signaling pathway—AREG—ovarian cancer	0.000157	0.0434	CbGpPWpGaD
Anastrozole—CYP1A2—Sulindac Metabolic Pathway—CYP1B1—ovarian cancer	0.000135	0.0373	CbGpPWpGaD
Anastrozole—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—ovarian cancer	0.000108	0.03	CbGpPWpGaD
Anastrozole—CYP19A1—Endogenous sterols—CYP1B1—ovarian cancer	0.000105	0.0291	CbGpPWpGaD
Anastrozole—CYP19A1—Ovarian Infertility Genes—MLH1—ovarian cancer	0.0001	0.0277	CbGpPWpGaD
Anastrozole—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—ovarian cancer	9.87e-05	0.0273	CbGpPWpGaD
Anastrozole—Lethargy—Doxorubicin—ovarian cancer	9.65e-05	0.000936	CcSEcCtD
Anastrozole—Leukopenia—Paclitaxel—ovarian cancer	9.63e-05	0.000935	CcSEcCtD
Anastrozole—Rash—Topotecan—ovarian cancer	9.63e-05	0.000934	CcSEcCtD
Anastrozole—Hypersensitivity—Vinorelbine—ovarian cancer	9.62e-05	0.000934	CcSEcCtD
Anastrozole—Dermatitis—Topotecan—ovarian cancer	9.62e-05	0.000933	CcSEcCtD
Anastrozole—Headache—Topotecan—ovarian cancer	9.56e-05	0.000928	CcSEcCtD
Anastrozole—CYP19A1—Ovarian Infertility Genes—PGR—ovarian cancer	9.51e-05	0.0263	CbGpPWpGaD
Anastrozole—Vomiting—Melphalan—ovarian cancer	9.5e-05	0.000922	CcSEcCtD
Anastrozole—Osteoarthritis—Doxorubicin—ovarian cancer	9.45e-05	0.000918	CcSEcCtD
Anastrozole—Liver function test abnormal—Epirubicin—ovarian cancer	9.43e-05	0.000916	CcSEcCtD
Anastrozole—Rash—Melphalan—ovarian cancer	9.42e-05	0.000915	CcSEcCtD
Anastrozole—Dermatitis—Melphalan—ovarian cancer	9.42e-05	0.000914	CcSEcCtD
Anastrozole—Cough—Paclitaxel—ovarian cancer	9.39e-05	0.000912	CcSEcCtD
Anastrozole—Asthenia—Vinorelbine—ovarian cancer	9.37e-05	0.000909	CcSEcCtD
Anastrozole—Hypertension—Paclitaxel—ovarian cancer	9.29e-05	0.000902	CcSEcCtD
Anastrozole—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—ovarian cancer	9.27e-05	0.0256	CbGpPWpGaD
Anastrozole—Alopecia—Docetaxel—ovarian cancer	9.26e-05	0.000899	CcSEcCtD
Anastrozole—Pruritus—Vinorelbine—ovarian cancer	9.24e-05	0.000897	CcSEcCtD
Anastrozole—Aspartate aminotransferase increased—Epirubicin—ovarian cancer	9.2e-05	0.000893	CcSEcCtD
Anastrozole—Myalgia—Paclitaxel—ovarian cancer	9.16e-05	0.000889	CcSEcCtD
Anastrozole—Chest pain—Paclitaxel—ovarian cancer	9.16e-05	0.000889	CcSEcCtD
Anastrozole—Arthralgia—Paclitaxel—ovarian cancer	9.16e-05	0.000889	CcSEcCtD
Anastrozole—Anxiety—Paclitaxel—ovarian cancer	9.13e-05	0.000886	CcSEcCtD
Anastrozole—Erythema—Docetaxel—ovarian cancer	9.12e-05	0.000885	CcSEcCtD
Anastrozole—Nausea—Topotecan—ovarian cancer	9.07e-05	0.00088	CcSEcCtD
Anastrozole—Discomfort—Paclitaxel—ovarian cancer	9.05e-05	0.000879	CcSEcCtD
Anastrozole—Alanine aminotransferase increased—Epirubicin—ovarian cancer	9.01e-05	0.000875	CcSEcCtD
Anastrozole—Dry mouth—Paclitaxel—ovarian cancer	8.96e-05	0.00087	CcSEcCtD
Anastrozole—Mood swings—Doxorubicin—ovarian cancer	8.96e-05	0.000869	CcSEcCtD
Anastrozole—Diarrhoea—Vinorelbine—ovarian cancer	8.94e-05	0.000867	CcSEcCtD
Anastrozole—Dysgeusia—Docetaxel—ovarian cancer	8.93e-05	0.000867	CcSEcCtD
Anastrozole—Nausea—Melphalan—ovarian cancer	8.88e-05	0.000862	CcSEcCtD
Anastrozole—Confusional state—Paclitaxel—ovarian cancer	8.86e-05	0.00086	CcSEcCtD
Anastrozole—Dysphagia—Epirubicin—ovarian cancer	8.83e-05	0.000857	CcSEcCtD
Anastrozole—Influenza—Epirubicin—ovarian cancer	8.83e-05	0.000857	CcSEcCtD
Anastrozole—Back pain—Docetaxel—ovarian cancer	8.82e-05	0.000857	CcSEcCtD
Anastrozole—Anaphylactic shock—Paclitaxel—ovarian cancer	8.78e-05	0.000853	CcSEcCtD
Anastrozole—Oedema—Paclitaxel—ovarian cancer	8.78e-05	0.000853	CcSEcCtD
Anastrozole—Liver function test abnormal—Doxorubicin—ovarian cancer	8.73e-05	0.000847	CcSEcCtD
Anastrozole—Infection—Paclitaxel—ovarian cancer	8.73e-05	0.000847	CcSEcCtD
Anastrozole—Dizziness—Vinorelbine—ovarian cancer	8.64e-05	0.000838	CcSEcCtD
Anastrozole—Angina pectoris—Epirubicin—ovarian cancer	8.6e-05	0.000835	CcSEcCtD
Anastrozole—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	8.51e-05	0.000826	CcSEcCtD
Anastrozole—Bronchitis—Epirubicin—ovarian cancer	8.49e-05	0.000824	CcSEcCtD
Anastrozole—Hyperhidrosis—Paclitaxel—ovarian cancer	8.49e-05	0.000824	CcSEcCtD
Anastrozole—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—ovarian cancer	8.43e-05	0.0233	CbGpPWpGaD
Anastrozole—Anaemia—Docetaxel—ovarian cancer	8.43e-05	0.000818	CcSEcCtD
Anastrozole—Anorexia—Paclitaxel—ovarian cancer	8.37e-05	0.000813	CcSEcCtD
Anastrozole—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	8.34e-05	0.000809	CcSEcCtD
Anastrozole—Vomiting—Vinorelbine—ovarian cancer	8.3e-05	0.000806	CcSEcCtD
Anastrozole—Rash—Vinorelbine—ovarian cancer	8.23e-05	0.000799	CcSEcCtD
Anastrozole—Dermatitis—Vinorelbine—ovarian cancer	8.23e-05	0.000798	CcSEcCtD
Anastrozole—Headache—Vinorelbine—ovarian cancer	8.18e-05	0.000794	CcSEcCtD
Anastrozole—Influenza—Doxorubicin—ovarian cancer	8.17e-05	0.000793	CcSEcCtD
Anastrozole—Dysphagia—Doxorubicin—ovarian cancer	8.17e-05	0.000793	CcSEcCtD
Anastrozole—Leukopenia—Docetaxel—ovarian cancer	8.17e-05	0.000793	CcSEcCtD
Anastrozole—Weight increased—Epirubicin—ovarian cancer	8.04e-05	0.00078	CcSEcCtD
Anastrozole—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	8e-05	0.000777	CcSEcCtD
Anastrozole—Weight decreased—Epirubicin—ovarian cancer	7.99e-05	0.000775	CcSEcCtD
Anastrozole—Cough—Docetaxel—ovarian cancer	7.96e-05	0.000773	CcSEcCtD
Anastrozole—Angina pectoris—Doxorubicin—ovarian cancer	7.96e-05	0.000773	CcSEcCtD
Anastrozole—Insomnia—Paclitaxel—ovarian cancer	7.94e-05	0.000771	CcSEcCtD
Anastrozole—Paraesthesia—Paclitaxel—ovarian cancer	7.89e-05	0.000766	CcSEcCtD
Anastrozole—Hypertension—Docetaxel—ovarian cancer	7.88e-05	0.000764	CcSEcCtD
Anastrozole—Bronchitis—Doxorubicin—ovarian cancer	7.86e-05	0.000763	CcSEcCtD
Anastrozole—Dyspnoea—Paclitaxel—ovarian cancer	7.83e-05	0.00076	CcSEcCtD
Anastrozole—Somnolence—Paclitaxel—ovarian cancer	7.81e-05	0.000758	CcSEcCtD
Anastrozole—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	7.81e-05	0.000758	CcSEcCtD
Anastrozole—Arthralgia—Docetaxel—ovarian cancer	7.77e-05	0.000754	CcSEcCtD
Anastrozole—Chest pain—Docetaxel—ovarian cancer	7.77e-05	0.000754	CcSEcCtD
Anastrozole—Myalgia—Docetaxel—ovarian cancer	7.77e-05	0.000754	CcSEcCtD
Anastrozole—Nausea—Vinorelbine—ovarian cancer	7.76e-05	0.000753	CcSEcCtD
Anastrozole—Dyspepsia—Paclitaxel—ovarian cancer	7.73e-05	0.00075	CcSEcCtD
Anastrozole—Neuropathy peripheral—Epirubicin—ovarian cancer	7.72e-05	0.000749	CcSEcCtD
Anastrozole—Jaundice—Epirubicin—ovarian cancer	7.67e-05	0.000745	CcSEcCtD
Anastrozole—Urinary tract infection—Epirubicin—ovarian cancer	7.65e-05	0.000743	CcSEcCtD
Anastrozole—Decreased appetite—Paclitaxel—ovarian cancer	7.64e-05	0.000741	CcSEcCtD
Anastrozole—CYP19A1—Ovarian Infertility Genes—CCND2—ovarian cancer	7.6e-05	0.021	CbGpPWpGaD
Anastrozole—Dry mouth—Docetaxel—ovarian cancer	7.6e-05	0.000737	CcSEcCtD
Anastrozole—Gastrointestinal disorder—Paclitaxel—ovarian cancer	7.58e-05	0.000736	CcSEcCtD
Anastrozole—Fatigue—Paclitaxel—ovarian cancer	7.57e-05	0.000735	CcSEcCtD
Anastrozole—Sweating—Epirubicin—ovarian cancer	7.55e-05	0.000733	CcSEcCtD
Anastrozole—Pain—Paclitaxel—ovarian cancer	7.51e-05	0.000729	CcSEcCtD
Anastrozole—Constipation—Paclitaxel—ovarian cancer	7.51e-05	0.000729	CcSEcCtD
Anastrozole—Confusional state—Docetaxel—ovarian cancer	7.51e-05	0.000729	CcSEcCtD
Anastrozole—Hepatobiliary disease—Epirubicin—ovarian cancer	7.45e-05	0.000723	CcSEcCtD
Anastrozole—Oedema—Docetaxel—ovarian cancer	7.45e-05	0.000723	CcSEcCtD
Anastrozole—Anaphylactic shock—Docetaxel—ovarian cancer	7.45e-05	0.000723	CcSEcCtD
Anastrozole—Weight increased—Doxorubicin—ovarian cancer	7.44e-05	0.000722	CcSEcCtD
Anastrozole—Infection—Docetaxel—ovarian cancer	7.4e-05	0.000718	CcSEcCtD
Anastrozole—Weight decreased—Doxorubicin—ovarian cancer	7.39e-05	0.000718	CcSEcCtD
Anastrozole—Sinusitis—Epirubicin—ovarian cancer	7.39e-05	0.000717	CcSEcCtD
Anastrozole—Feeling abnormal—Paclitaxel—ovarian cancer	7.24e-05	0.000703	CcSEcCtD
Anastrozole—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	7.22e-05	0.000701	CcSEcCtD
Anastrozole—Gastrointestinal pain—Paclitaxel—ovarian cancer	7.18e-05	0.000697	CcSEcCtD
Anastrozole—Neuropathy peripheral—Doxorubicin—ovarian cancer	7.14e-05	0.000693	CcSEcCtD
Anastrozole—Haemoglobin—Epirubicin—ovarian cancer	7.1e-05	0.00069	CcSEcCtD
Anastrozole—Jaundice—Doxorubicin—ovarian cancer	7.1e-05	0.000689	CcSEcCtD
Anastrozole—Anorexia—Docetaxel—ovarian cancer	7.1e-05	0.000689	CcSEcCtD
Anastrozole—Rhinitis—Epirubicin—ovarian cancer	7.09e-05	0.000688	CcSEcCtD
Anastrozole—Urinary tract infection—Doxorubicin—ovarian cancer	7.08e-05	0.000687	CcSEcCtD
Anastrozole—Haemorrhage—Epirubicin—ovarian cancer	7.07e-05	0.000686	CcSEcCtD
Anastrozole—Hepatitis—Epirubicin—ovarian cancer	7.07e-05	0.000686	CcSEcCtD
Anastrozole—Pharyngitis—Epirubicin—ovarian cancer	7.02e-05	0.000681	CcSEcCtD
Anastrozole—Sweating—Doxorubicin—ovarian cancer	6.98e-05	0.000678	CcSEcCtD
Anastrozole—Urticaria—Paclitaxel—ovarian cancer	6.98e-05	0.000677	CcSEcCtD
Anastrozole—Oedema peripheral—Epirubicin—ovarian cancer	6.96e-05	0.000676	CcSEcCtD
Anastrozole—Body temperature increased—Paclitaxel—ovarian cancer	6.94e-05	0.000674	CcSEcCtD
Anastrozole—Abdominal pain—Paclitaxel—ovarian cancer	6.94e-05	0.000674	CcSEcCtD
Anastrozole—Hepatobiliary disease—Doxorubicin—ovarian cancer	6.89e-05	0.000669	CcSEcCtD
Anastrozole—Sinusitis—Doxorubicin—ovarian cancer	6.83e-05	0.000663	CcSEcCtD
Anastrozole—Musculoskeletal discomfort—Docetaxel—ovarian cancer	6.78e-05	0.000658	CcSEcCtD
Anastrozole—Insomnia—Docetaxel—ovarian cancer	6.73e-05	0.000654	CcSEcCtD
Anastrozole—Paraesthesia—Docetaxel—ovarian cancer	6.69e-05	0.000649	CcSEcCtD
Anastrozole—Erythema multiforme—Epirubicin—ovarian cancer	6.68e-05	0.000649	CcSEcCtD
Anastrozole—Dyspnoea—Docetaxel—ovarian cancer	6.64e-05	0.000644	CcSEcCtD
Anastrozole—Somnolence—Docetaxel—ovarian cancer	6.62e-05	0.000642	CcSEcCtD
Anastrozole—Haemoglobin—Doxorubicin—ovarian cancer	6.57e-05	0.000638	CcSEcCtD
Anastrozole—CYP3A4—Liver X Receptor Pathway—FASN—ovarian cancer	6.57e-05	0.0182	CbGpPWpGaD
Anastrozole—Rhinitis—Doxorubicin—ovarian cancer	6.56e-05	0.000636	CcSEcCtD
Anastrozole—Dyspepsia—Docetaxel—ovarian cancer	6.55e-05	0.000636	CcSEcCtD
Anastrozole—Haemorrhage—Doxorubicin—ovarian cancer	6.54e-05	0.000635	CcSEcCtD
Anastrozole—Hepatitis—Doxorubicin—ovarian cancer	6.54e-05	0.000635	CcSEcCtD
Anastrozole—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—ovarian cancer	6.51e-05	0.018	CbGpPWpGaD
Anastrozole—Pharyngitis—Doxorubicin—ovarian cancer	6.49e-05	0.00063	CcSEcCtD
Anastrozole—Decreased appetite—Docetaxel—ovarian cancer	6.47e-05	0.000628	CcSEcCtD
Anastrozole—Hypersensitivity—Paclitaxel—ovarian cancer	6.47e-05	0.000628	CcSEcCtD
Anastrozole—Oedema peripheral—Doxorubicin—ovarian cancer	6.44e-05	0.000625	CcSEcCtD
Anastrozole—Gastrointestinal disorder—Docetaxel—ovarian cancer	6.43e-05	0.000624	CcSEcCtD
Anastrozole—Fatigue—Docetaxel—ovarian cancer	6.42e-05	0.000623	CcSEcCtD
Anastrozole—Constipation—Docetaxel—ovarian cancer	6.37e-05	0.000618	CcSEcCtD
Anastrozole—Pain—Docetaxel—ovarian cancer	6.37e-05	0.000618	CcSEcCtD
Anastrozole—Asthenia—Paclitaxel—ovarian cancer	6.3e-05	0.000612	CcSEcCtD
Anastrozole—CYP1A2—Estrogen Receptor Pathway—CYP1B1—ovarian cancer	6.28e-05	0.0174	CbGpPWpGaD
Anastrozole—Alopecia—Epirubicin—ovarian cancer	6.25e-05	0.000606	CcSEcCtD
Anastrozole—Pruritus—Paclitaxel—ovarian cancer	6.21e-05	0.000603	CcSEcCtD
Anastrozole—Erythema multiforme—Doxorubicin—ovarian cancer	6.18e-05	0.0006	CcSEcCtD
Anastrozole—Erythema—Epirubicin—ovarian cancer	6.15e-05	0.000597	CcSEcCtD
Anastrozole—Feeling abnormal—Docetaxel—ovarian cancer	6.14e-05	0.000596	CcSEcCtD
Anastrozole—Gastrointestinal pain—Docetaxel—ovarian cancer	6.09e-05	0.000591	CcSEcCtD
Anastrozole—CYP19A1—Tryptophan metabolism—CYP1B1—ovarian cancer	6.05e-05	0.0167	CbGpPWpGaD
Anastrozole—Tension—Epirubicin—ovarian cancer	6.04e-05	0.000586	CcSEcCtD
Anastrozole—Dysgeusia—Epirubicin—ovarian cancer	6.03e-05	0.000585	CcSEcCtD
Anastrozole—Diarrhoea—Paclitaxel—ovarian cancer	6.01e-05	0.000583	CcSEcCtD
Anastrozole—Nervousness—Epirubicin—ovarian cancer	5.98e-05	0.00058	CcSEcCtD
Anastrozole—Back pain—Epirubicin—ovarian cancer	5.95e-05	0.000578	CcSEcCtD
Anastrozole—CYP3A4—Codeine and Morphine Metabolism—ABCB1—ovarian cancer	5.89e-05	0.0163	CbGpPWpGaD
Anastrozole—Abdominal pain—Docetaxel—ovarian cancer	5.89e-05	0.000571	CcSEcCtD
Anastrozole—Body temperature increased—Docetaxel—ovarian cancer	5.89e-05	0.000571	CcSEcCtD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—BARD1—ovarian cancer	5.87e-05	0.0162	CbGpPWpGaD
Anastrozole—Dizziness—Paclitaxel—ovarian cancer	5.81e-05	0.000564	CcSEcCtD
Anastrozole—Alopecia—Doxorubicin—ovarian cancer	5.78e-05	0.000561	CcSEcCtD
Anastrozole—Ill-defined disorder—Epirubicin—ovarian cancer	5.71e-05	0.000554	CcSEcCtD
Anastrozole—Erythema—Doxorubicin—ovarian cancer	5.69e-05	0.000553	CcSEcCtD
Anastrozole—Anaemia—Epirubicin—ovarian cancer	5.69e-05	0.000552	CcSEcCtD
Anastrozole—Tension—Doxorubicin—ovarian cancer	5.59e-05	0.000542	CcSEcCtD
Anastrozole—Vomiting—Paclitaxel—ovarian cancer	5.58e-05	0.000542	CcSEcCtD
Anastrozole—Dysgeusia—Doxorubicin—ovarian cancer	5.58e-05	0.000541	CcSEcCtD
Anastrozole—Malaise—Epirubicin—ovarian cancer	5.55e-05	0.000539	CcSEcCtD
Anastrozole—Rash—Paclitaxel—ovarian cancer	5.54e-05	0.000538	CcSEcCtD
Anastrozole—Dermatitis—Paclitaxel—ovarian cancer	5.53e-05	0.000537	CcSEcCtD
Anastrozole—Nervousness—Doxorubicin—ovarian cancer	5.53e-05	0.000537	CcSEcCtD
Anastrozole—Leukopenia—Epirubicin—ovarian cancer	5.51e-05	0.000535	CcSEcCtD
Anastrozole—Back pain—Doxorubicin—ovarian cancer	5.51e-05	0.000535	CcSEcCtD
Anastrozole—Headache—Paclitaxel—ovarian cancer	5.5e-05	0.000534	CcSEcCtD
Anastrozole—Hypersensitivity—Docetaxel—ovarian cancer	5.49e-05	0.000532	CcSEcCtD
Anastrozole—Cough—Epirubicin—ovarian cancer	5.37e-05	0.000521	CcSEcCtD
Anastrozole—Asthenia—Docetaxel—ovarian cancer	5.34e-05	0.000518	CcSEcCtD
Anastrozole—Hypertension—Epirubicin—ovarian cancer	5.31e-05	0.000516	CcSEcCtD
Anastrozole—Ill-defined disorder—Doxorubicin—ovarian cancer	5.28e-05	0.000513	CcSEcCtD
Anastrozole—Pruritus—Docetaxel—ovarian cancer	5.27e-05	0.000511	CcSEcCtD
Anastrozole—Anaemia—Doxorubicin—ovarian cancer	5.26e-05	0.000511	CcSEcCtD
Anastrozole—Myalgia—Epirubicin—ovarian cancer	5.24e-05	0.000508	CcSEcCtD
Anastrozole—Arthralgia—Epirubicin—ovarian cancer	5.24e-05	0.000508	CcSEcCtD
Anastrozole—Chest pain—Epirubicin—ovarian cancer	5.24e-05	0.000508	CcSEcCtD
Anastrozole—Anxiety—Epirubicin—ovarian cancer	5.22e-05	0.000507	CcSEcCtD
Anastrozole—Nausea—Paclitaxel—ovarian cancer	5.22e-05	0.000506	CcSEcCtD
Anastrozole—Discomfort—Epirubicin—ovarian cancer	5.18e-05	0.000502	CcSEcCtD
Anastrozole—Malaise—Doxorubicin—ovarian cancer	5.13e-05	0.000498	CcSEcCtD
Anastrozole—Dry mouth—Epirubicin—ovarian cancer	5.12e-05	0.000497	CcSEcCtD
Anastrozole—Leukopenia—Doxorubicin—ovarian cancer	5.1e-05	0.000495	CcSEcCtD
Anastrozole—Diarrhoea—Docetaxel—ovarian cancer	5.09e-05	0.000494	CcSEcCtD
Anastrozole—Confusional state—Epirubicin—ovarian cancer	5.06e-05	0.000491	CcSEcCtD
Anastrozole—Anaphylactic shock—Epirubicin—ovarian cancer	5.02e-05	0.000487	CcSEcCtD
Anastrozole—Oedema—Epirubicin—ovarian cancer	5.02e-05	0.000487	CcSEcCtD
Anastrozole—CYP2C9—Tamoxifen metabolism—CYP1B1—ovarian cancer	5.01e-05	0.0138	CbGpPWpGaD
Anastrozole—Infection—Epirubicin—ovarian cancer	4.99e-05	0.000484	CcSEcCtD
Anastrozole—Cough—Doxorubicin—ovarian cancer	4.97e-05	0.000482	CcSEcCtD
Anastrozole—Dizziness—Docetaxel—ovarian cancer	4.92e-05	0.000478	CcSEcCtD
Anastrozole—Hypertension—Doxorubicin—ovarian cancer	4.92e-05	0.000477	CcSEcCtD
Anastrozole—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	4.89e-05	0.0135	CbGpPWpGaD
Anastrozole—Hyperhidrosis—Epirubicin—ovarian cancer	4.85e-05	0.000471	CcSEcCtD
Anastrozole—Myalgia—Doxorubicin—ovarian cancer	4.85e-05	0.00047	CcSEcCtD
Anastrozole—Chest pain—Doxorubicin—ovarian cancer	4.85e-05	0.00047	CcSEcCtD
Anastrozole—Arthralgia—Doxorubicin—ovarian cancer	4.85e-05	0.00047	CcSEcCtD
Anastrozole—CYP1A2—Estrogen metabolism—CYP1B1—ovarian cancer	4.84e-05	0.0134	CbGpPWpGaD
Anastrozole—Anxiety—Doxorubicin—ovarian cancer	4.83e-05	0.000469	CcSEcCtD
Anastrozole—CYP19A1—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	4.83e-05	0.0133	CbGpPWpGaD
Anastrozole—Discomfort—Doxorubicin—ovarian cancer	4.79e-05	0.000465	CcSEcCtD
Anastrozole—Anorexia—Epirubicin—ovarian cancer	4.79e-05	0.000465	CcSEcCtD
Anastrozole—Dry mouth—Doxorubicin—ovarian cancer	4.74e-05	0.00046	CcSEcCtD
Anastrozole—Vomiting—Docetaxel—ovarian cancer	4.73e-05	0.000459	CcSEcCtD
Anastrozole—Rash—Docetaxel—ovarian cancer	4.69e-05	0.000456	CcSEcCtD
Anastrozole—Dermatitis—Docetaxel—ovarian cancer	4.69e-05	0.000455	CcSEcCtD
Anastrozole—Confusional state—Doxorubicin—ovarian cancer	4.69e-05	0.000455	CcSEcCtD
Anastrozole—Headache—Docetaxel—ovarian cancer	4.66e-05	0.000453	CcSEcCtD
Anastrozole—Anaphylactic shock—Doxorubicin—ovarian cancer	4.65e-05	0.000451	CcSEcCtD
Anastrozole—Oedema—Doxorubicin—ovarian cancer	4.65e-05	0.000451	CcSEcCtD
Anastrozole—Infection—Doxorubicin—ovarian cancer	4.62e-05	0.000448	CcSEcCtD
Anastrozole—Musculoskeletal discomfort—Epirubicin—ovarian cancer	4.58e-05	0.000444	CcSEcCtD
Anastrozole—Insomnia—Epirubicin—ovarian cancer	4.54e-05	0.000441	CcSEcCtD
Anastrozole—Paraesthesia—Epirubicin—ovarian cancer	4.51e-05	0.000438	CcSEcCtD
Anastrozole—Hyperhidrosis—Doxorubicin—ovarian cancer	4.49e-05	0.000436	CcSEcCtD
Anastrozole—Dyspnoea—Epirubicin—ovarian cancer	4.48e-05	0.000435	CcSEcCtD
Anastrozole—Somnolence—Epirubicin—ovarian cancer	4.46e-05	0.000433	CcSEcCtD
Anastrozole—Anorexia—Doxorubicin—ovarian cancer	4.43e-05	0.00043	CcSEcCtD
Anastrozole—Nausea—Docetaxel—ovarian cancer	4.42e-05	0.000429	CcSEcCtD
Anastrozole—Dyspepsia—Epirubicin—ovarian cancer	4.42e-05	0.000429	CcSEcCtD
Anastrozole—Decreased appetite—Epirubicin—ovarian cancer	4.37e-05	0.000424	CcSEcCtD
Anastrozole—Gastrointestinal disorder—Epirubicin—ovarian cancer	4.34e-05	0.000421	CcSEcCtD
Anastrozole—Fatigue—Epirubicin—ovarian cancer	4.33e-05	0.00042	CcSEcCtD
Anastrozole—Pain—Epirubicin—ovarian cancer	4.29e-05	0.000417	CcSEcCtD
Anastrozole—Constipation—Epirubicin—ovarian cancer	4.29e-05	0.000417	CcSEcCtD
Anastrozole—CYP1A2—Tamoxifen metabolism—CYP1B1—ovarian cancer	4.28e-05	0.0118	CbGpPWpGaD
Anastrozole—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	4.23e-05	0.000411	CcSEcCtD
Anastrozole—CYP19A1—FSH signaling pathway—MTOR—ovarian cancer	4.21e-05	0.0116	CbGpPWpGaD
Anastrozole—Insomnia—Doxorubicin—ovarian cancer	4.2e-05	0.000408	CcSEcCtD
Anastrozole—Paraesthesia—Doxorubicin—ovarian cancer	4.17e-05	0.000405	CcSEcCtD
Anastrozole—Dyspnoea—Doxorubicin—ovarian cancer	4.14e-05	0.000402	CcSEcCtD
Anastrozole—Feeling abnormal—Epirubicin—ovarian cancer	4.14e-05	0.000402	CcSEcCtD
Anastrozole—Somnolence—Doxorubicin—ovarian cancer	4.13e-05	0.000401	CcSEcCtD
Anastrozole—Gastrointestinal pain—Epirubicin—ovarian cancer	4.11e-05	0.000399	CcSEcCtD
Anastrozole—Dyspepsia—Doxorubicin—ovarian cancer	4.09e-05	0.000397	CcSEcCtD
Anastrozole—Decreased appetite—Doxorubicin—ovarian cancer	4.04e-05	0.000392	CcSEcCtD
Anastrozole—Gastrointestinal disorder—Doxorubicin—ovarian cancer	4.01e-05	0.000389	CcSEcCtD
Anastrozole—Fatigue—Doxorubicin—ovarian cancer	4.01e-05	0.000389	CcSEcCtD
Anastrozole—Urticaria—Epirubicin—ovarian cancer	3.99e-05	0.000387	CcSEcCtD
Anastrozole—Pain—Doxorubicin—ovarian cancer	3.97e-05	0.000386	CcSEcCtD
Anastrozole—Constipation—Doxorubicin—ovarian cancer	3.97e-05	0.000386	CcSEcCtD
Anastrozole—Body temperature increased—Epirubicin—ovarian cancer	3.97e-05	0.000385	CcSEcCtD
Anastrozole—Abdominal pain—Epirubicin—ovarian cancer	3.97e-05	0.000385	CcSEcCtD
Anastrozole—CYP19A1—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	3.96e-05	0.011	CbGpPWpGaD
Anastrozole—CYP1A2—Estrogen Receptor Pathway—ESR1—ovarian cancer	3.95e-05	0.0109	CbGpPWpGaD
Anastrozole—Feeling abnormal—Doxorubicin—ovarian cancer	3.83e-05	0.000372	CcSEcCtD
Anastrozole—Gastrointestinal pain—Doxorubicin—ovarian cancer	3.8e-05	0.000369	CcSEcCtD
Anastrozole—CYP3A4—Estrogen metabolism—CYP1B1—ovarian cancer	3.74e-05	0.0103	CbGpPWpGaD
Anastrozole—Hypersensitivity—Epirubicin—ovarian cancer	3.7e-05	0.000359	CcSEcCtD
Anastrozole—Urticaria—Doxorubicin—ovarian cancer	3.69e-05	0.000358	CcSEcCtD
Anastrozole—Abdominal pain—Doxorubicin—ovarian cancer	3.67e-05	0.000357	CcSEcCtD
Anastrozole—Body temperature increased—Doxorubicin—ovarian cancer	3.67e-05	0.000357	CcSEcCtD
Anastrozole—Asthenia—Epirubicin—ovarian cancer	3.6e-05	0.00035	CcSEcCtD
Anastrozole—Pruritus—Epirubicin—ovarian cancer	3.55e-05	0.000345	CcSEcCtD
Anastrozole—CYP19A1—Ovarian Infertility Genes—CDKN1B—ovarian cancer	3.45e-05	0.00954	CbGpPWpGaD
Anastrozole—Diarrhoea—Epirubicin—ovarian cancer	3.44e-05	0.000334	CcSEcCtD
Anastrozole—Hypersensitivity—Doxorubicin—ovarian cancer	3.42e-05	0.000332	CcSEcCtD
Anastrozole—Asthenia—Doxorubicin—ovarian cancer	3.33e-05	0.000324	CcSEcCtD
Anastrozole—Dizziness—Epirubicin—ovarian cancer	3.32e-05	0.000322	CcSEcCtD
Anastrozole—CYP1A2—Melatonin metabolism and effects—CYP1B1—ovarian cancer	3.31e-05	0.00914	CbGpPWpGaD
Anastrozole—CYP3A4—Tamoxifen metabolism—CYP1B1—ovarian cancer	3.3e-05	0.00913	CbGpPWpGaD
Anastrozole—Pruritus—Doxorubicin—ovarian cancer	3.29e-05	0.000319	CcSEcCtD
Anastrozole—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—ovarian cancer	3.22e-05	0.00891	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—MSH2—ovarian cancer	3.22e-05	0.00889	CbGpPWpGaD
Anastrozole—Vomiting—Epirubicin—ovarian cancer	3.19e-05	0.00031	CcSEcCtD
Anastrozole—Diarrhoea—Doxorubicin—ovarian cancer	3.18e-05	0.000309	CcSEcCtD
Anastrozole—Rash—Epirubicin—ovarian cancer	3.17e-05	0.000307	CcSEcCtD
Anastrozole—Dermatitis—Epirubicin—ovarian cancer	3.16e-05	0.000307	CcSEcCtD
Anastrozole—Headache—Epirubicin—ovarian cancer	3.15e-05	0.000305	CcSEcCtD
Anastrozole—CYP19A1—FSH signaling pathway—MAPK3—ovarian cancer	3.11e-05	0.0086	CbGpPWpGaD
Anastrozole—Dizziness—Doxorubicin—ovarian cancer	3.07e-05	0.000298	CcSEcCtD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—SMARCA4—ovarian cancer	3e-05	0.0083	CbGpPWpGaD
Anastrozole—Nausea—Epirubicin—ovarian cancer	2.98e-05	0.00029	CcSEcCtD
Anastrozole—CYP19A1—FSH signaling pathway—MAPK1—ovarian cancer	2.96e-05	0.00818	CbGpPWpGaD
Anastrozole—Vomiting—Doxorubicin—ovarian cancer	2.95e-05	0.000287	CcSEcCtD
Anastrozole—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	2.95e-05	0.00814	CbGpPWpGaD
Anastrozole—Rash—Doxorubicin—ovarian cancer	2.93e-05	0.000284	CcSEcCtD
Anastrozole—Dermatitis—Doxorubicin—ovarian cancer	2.93e-05	0.000284	CcSEcCtD
Anastrozole—Headache—Doxorubicin—ovarian cancer	2.91e-05	0.000283	CcSEcCtD
Anastrozole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	2.81e-05	0.00776	CbGpPWpGaD
Anastrozole—Nausea—Doxorubicin—ovarian cancer	2.76e-05	0.000268	CcSEcCtD
Anastrozole—CYP3A4—Irinotecan Pathway—APC—ovarian cancer	2.71e-05	0.0075	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—GADD45A—ovarian cancer	2.57e-05	0.00709	CbGpPWpGaD
Anastrozole—CYP2C9—Arachidonic acid metabolism—CYP1B1—ovarian cancer	2.5e-05	0.00692	CbGpPWpGaD
Anastrozole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	2.4e-05	0.00663	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—CHEK2—ovarian cancer	2.34e-05	0.00648	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1B1—ovarian cancer	2.29e-05	0.00632	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—CYP1B1—ovarian cancer	2.29e-05	0.00632	CbGpPWpGaD
Anastrozole—CYP1A2—Tryptophan metabolism—CYP1B1—ovarian cancer	2.29e-05	0.00632	CbGpPWpGaD
Anastrozole—CYP1A2—Estrogen Receptor Pathway—STAT3—ovarian cancer	2.21e-05	0.0061	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—BRCA1—ovarian cancer	2.2e-05	0.00607	CbGpPWpGaD
Anastrozole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	2.16e-05	0.00598	CbGpPWpGaD
Anastrozole—CYP1A2—Arachidonic acid metabolism—CYP1B1—ovarian cancer	2.14e-05	0.00591	CbGpPWpGaD
Anastrozole—CYP2C9—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	2.14e-05	0.0059	CbGpPWpGaD
Anastrozole—CYP19A1—Biological oxidations—CYP1B1—ovarian cancer	2.11e-05	0.00582	CbGpPWpGaD
Anastrozole—CYP19A1—FSH signaling pathway—AKT1—ovarian cancer	2.1e-05	0.0058	CbGpPWpGaD
Anastrozole—CYP19A1—Metapathway biotransformation—CYP1B1—ovarian cancer	2.08e-05	0.00574	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—BRCA2—ovarian cancer	1.99e-05	0.00549	CbGpPWpGaD
Anastrozole—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	1.94e-05	0.00537	CbGpPWpGaD
Anastrozole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	1.85e-05	0.00512	CbGpPWpGaD
Anastrozole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	1.85e-05	0.00511	CbGpPWpGaD
Anastrozole—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	1.82e-05	0.00504	CbGpPWpGaD
Anastrozole—CYP3A4—Tryptophan metabolism—CYP1B1—ovarian cancer	1.76e-05	0.00488	CbGpPWpGaD
Anastrozole—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	1.75e-05	0.00485	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	1.62e-05	0.00449	CbGpPWpGaD
Anastrozole—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	1.5e-05	0.00414	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—ESR1—ovarian cancer	1.47e-05	0.00406	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—ovarian cancer	1.44e-05	0.00397	CbGpPWpGaD
Anastrozole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	1.43e-05	0.00394	CbGpPWpGaD
Anastrozole—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	1.41e-05	0.00389	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—NME2—ovarian cancer	1.28e-05	0.00355	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—CDH1—ovarian cancer	1.28e-05	0.00353	CbGpPWpGaD
Anastrozole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	1.16e-05	0.0032	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	1.09e-05	0.00301	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—MTOR—ovarian cancer	1.06e-05	0.00294	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—CASP3—ovarian cancer	9.78e-06	0.0027	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ovarian cancer	9.76e-06	0.0027	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—ovarian cancer	9.76e-06	0.0027	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—ovarian cancer	9.55e-06	0.00264	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—CCND1—ovarian cancer	9.52e-06	0.00263	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—ovarian cancer	9.42e-06	0.0026	CbGpPWpGaD
Anastrozole—CYP2C9—Biological oxidations—CYP1B1—ovarian cancer	9.32e-06	0.00257	CbGpPWpGaD
Anastrozole—CYP2C9—Metapathway biotransformation—CYP1B1—ovarian cancer	9.19e-06	0.00254	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—PTEN—ovarian cancer	9.18e-06	0.00254	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	8.88e-06	0.00245	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—ovarian cancer	8.3e-06	0.00229	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—CYTB—ovarian cancer	8.27e-06	0.00229	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—ovarian cancer	8.12e-06	0.00224	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	8.09e-06	0.00223	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—ovarian cancer	8.02e-06	0.00222	CbGpPWpGaD
Anastrozole—CYP1A2—Biological oxidations—CYP1B1—ovarian cancer	7.96e-06	0.0022	CbGpPWpGaD
Anastrozole—CYP1A2—Metapathway biotransformation—CYP1B1—ovarian cancer	7.85e-06	0.00217	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—MYC—ovarian cancer	7.63e-06	0.00211	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—MYC—ovarian cancer	7.47e-06	0.00206	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—MAPK1—ovarian cancer	7.47e-06	0.00206	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—EGFR—ovarian cancer	7.47e-06	0.00206	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—ovarian cancer	7.31e-06	0.00202	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—ovarian cancer	7.31e-06	0.00202	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—ovarian cancer	7.31e-06	0.00202	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—BRIP1—ovarian cancer	7.23e-06	0.002	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—PPP1CC—ovarian cancer	7.23e-06	0.002	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	7.18e-06	0.00199	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—KRAS—ovarian cancer	7.05e-06	0.00195	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—ovarian cancer	6.9e-06	0.00191	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—TP53—ovarian cancer	6.27e-06	0.00173	CbGpPWpGaD
Anastrozole—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	6.14e-06	0.0017	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	6.14e-06	0.0017	CbGpPWpGaD
Anastrozole—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	6.06e-06	0.00167	CbGpPWpGaD
Anastrozole—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—ovarian cancer	5.87e-06	0.00162	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—NME2—ovarian cancer	5.68e-06	0.00157	CbGpPWpGaD
Anastrozole—CYP19A1—Integrated Breast Cancer Pathway—AKT1—ovarian cancer	5.29e-06	0.00146	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	5.27e-06	0.00146	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—NME2—ovarian cancer	4.85e-06	0.00134	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—YAP1—ovarian cancer	4.85e-06	0.00134	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	4.82e-06	0.00133	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	4.8e-06	0.00133	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	4.22e-06	0.00117	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	4.12e-06	0.00114	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—FASN—ovarian cancer	3.95e-06	0.00109	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	3.93e-06	0.00109	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—SLC5A5—ovarian cancer	3.89e-06	0.00107	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—SLC2A1—ovarian cancer	3.76e-06	0.00104	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—NME2—ovarian cancer	3.75e-06	0.00104	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	3.68e-06	0.00102	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—CYTB—ovarian cancer	3.66e-06	0.00101	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—CYP1B1—ovarian cancer	3.6e-06	0.000995	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	3.58e-06	0.000989	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	3.36e-06	0.000928	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—BRIP1—ovarian cancer	3.2e-06	0.000884	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—PPP1CC—ovarian cancer	3.2e-06	0.000884	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—PPP2R1A—ovarian cancer	3.19e-06	0.000883	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	3.18e-06	0.000878	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—CYTB—ovarian cancer	3.13e-06	0.000864	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	3.06e-06	0.000845	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—ABCB1—ovarian cancer	2.97e-06	0.000819	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—TYMS—ovarian cancer	2.91e-06	0.000805	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—PPP1CC—ovarian cancer	2.73e-06	0.000756	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—BRIP1—ovarian cancer	2.73e-06	0.000756	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—CYTB—ovarian cancer	2.41e-06	0.000667	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—CAV1—ovarian cancer	2.35e-06	0.000648	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	2.33e-06	0.000644	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.24e-06	0.00062	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—YAP1—ovarian cancer	2.15e-06	0.000593	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—PIK3CG—ovarian cancer	2.14e-06	0.000591	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	2.12e-06	0.000587	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—BRIP1—ovarian cancer	2.11e-06	0.000583	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—PPP1CC—ovarian cancer	2.11e-06	0.000583	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.99e-06	0.000551	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—PIK3CD—ovarian cancer	1.88e-06	0.000519	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.87e-06	0.000516	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—YAP1—ovarian cancer	1.83e-06	0.000507	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.81e-06	0.000502	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—FASN—ovarian cancer	1.75e-06	0.000483	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—SLC5A5—ovarian cancer	1.72e-06	0.000476	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—SLC2A1—ovarian cancer	1.66e-06	0.000459	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—PIK3CB—ovarian cancer	1.64e-06	0.000453	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.63e-06	0.00045	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.6e-06	0.000441	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—CYP1B1—ovarian cancer	1.59e-06	0.00044	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—FASN—ovarian cancer	1.49e-06	0.000413	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—SLC5A5—ovarian cancer	1.47e-06	0.000406	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—SLC2A1—ovarian cancer	1.42e-06	0.000392	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—YAP1—ovarian cancer	1.42e-06	0.000391	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—PTEN—ovarian cancer	1.42e-06	0.000391	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	1.41e-06	0.000391	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.41e-06	0.000389	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.39e-06	0.000384	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—CYP1B1—ovarian cancer	1.36e-06	0.000376	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—ABCB1—ovarian cancer	1.31e-06	0.000363	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—TYMS—ovarian cancer	1.29e-06	0.000356	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	1.21e-06	0.000334	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.2e-06	0.000332	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—FASN—ovarian cancer	1.15e-06	0.000319	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—SLC5A5—ovarian cancer	1.13e-06	0.000314	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—ABCB1—ovarian cancer	1.12e-06	0.00031	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—TYMS—ovarian cancer	1.1e-06	0.000304	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—SLC2A1—ovarian cancer	1.1e-06	0.000303	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—CYP1B1—ovarian cancer	1.05e-06	0.00029	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—CAV1—ovarian cancer	1.04e-06	0.000287	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—PIK3CA—ovarian cancer	9.98e-07	0.000276	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	9.92e-07	0.000274	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—PIK3CG—ovarian cancer	9.46e-07	0.000261	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	9.32e-07	0.000258	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—CAV1—ovarian cancer	8.87e-07	0.000245	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—ABCB1—ovarian cancer	8.65e-07	0.000239	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—TYMS—ovarian cancer	8.5e-07	0.000235	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	8.48e-07	0.000234	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—PIK3CD—ovarian cancer	8.31e-07	0.00023	CbGpPWpGaD
Anastrozole—CYP19A1—Metabolism—AKT1—ovarian cancer	8.16e-07	0.000225	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—PIK3CG—ovarian cancer	8.08e-07	0.000223	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—PIK3CB—ovarian cancer	7.25e-07	0.0002	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—PIK3CD—ovarian cancer	7.11e-07	0.000196	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—CAV1—ovarian cancer	6.85e-07	0.000189	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—PTEN—ovarian cancer	6.26e-07	0.000173	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—PIK3CG—ovarian cancer	6.24e-07	0.000172	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—PIK3CB—ovarian cancer	6.19e-07	0.000171	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—PIK3CD—ovarian cancer	5.48e-07	0.000152	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—PTEN—ovarian cancer	5.35e-07	0.000148	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—PIK3CB—ovarian cancer	4.78e-07	0.000132	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—PIK3CA—ovarian cancer	4.42e-07	0.000122	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—PTEN—ovarian cancer	4.13e-07	0.000114	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—PIK3CA—ovarian cancer	3.78e-07	0.000104	CbGpPWpGaD
Anastrozole—CYP2C9—Metabolism—AKT1—ovarian cancer	3.61e-07	9.97e-05	CbGpPWpGaD
Anastrozole—CYP1A2—Metabolism—AKT1—ovarian cancer	3.08e-07	8.52e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—PIK3CA—ovarian cancer	2.91e-07	8.05e-05	CbGpPWpGaD
Anastrozole—CYP3A4—Metabolism—AKT1—ovarian cancer	2.38e-07	6.58e-05	CbGpPWpGaD
